Myda Advisors LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Myda Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.28 - $1.16 $140,000 - $580,000	500,000 New	500,000 $165,000
Q3 2022 Nov 10, 2022	BUY	$0.73 - $3.74 $21,900 - $112,200	30,000 Added 14.29%	240,000 $749,000
Q2 2022 Aug 12, 2022	BUY	$2.2 - $4.2 $114,400 - $218,400	52,000 Added 32.91%	210,000 $500,000
Q1 2022 May 13, 2022	BUY	$2.83 - $8.69 $447,140 - $1.37 Million	158,000 New	158,000 $637,000
Q4 2021 Feb 11, 2022	SELL	$8.31 - $14.92 $550,786 - $988,897	-66,280 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$9.15 - $13.28 $606,462 - $880,198	66,280 New	66,280 $768,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $12.1B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Myda Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Myda Advisors LLC with notifications on news.